Don’t Miss the Latest Life Science Resources
Top 10 Life Science Resources
Your time is precious. Therefore, we’ve curated a selection of recently published expert insights, tips, case studies, and scientific and regulatory information, just for you.
Discover how integrated preclinical and bioanalytical services can benefit your gene therapy requirements, what platforms are available, and what advancements in gene therapy treatments our experts are anticipating. Read the blog.
2. Webinar: Sinclair Nanopig™–The Next Generation, Non-Rodent Model for (Bio)Pharmaceuticals Safety Assessment
Learn about the advantages of factoring miniature swine into your species selection considerations, from cost-efficiency to lower body weight, and comparable toxicological data to beagles and Göttingen minipigs. Watch the webinar.
3. eBook: First-in-Human Solutions for Small and Large Molecules
Explore the benefits of a customized and integrated approach to your first-in-human (FIH) clinical trials. Read the eBook.
4. Webinar: On the Edge of Dermatology Early-Phase Trial
Innovaderm invited Altasciences for a roundtable discussion on the current landscape in early-phase dermatology clinical trials. Discover how these trials are instrumental in shaping innovative treatments and therapeutic strategies for dermatological conditions. Watch the webinar.
5. Fact Sheet: Flow Cytometry Services
Uncover the scope of flow cytometry services available to you when partnering with Altasciences for your immunology and cell-based research. Read now.
6. Podcast: Sparking the Evolution of Microsampling with the Mitra® VAMS® Device
Jeff Plomley, Scientific Director, Method Development, discusses the history and evolution of microsampling with guest Dr. James Rudge, the co-inventor of the Mitra® VAMS® device, and Microsampling Technical Director of Neoteryx. Listen to the podcast.
7. Infographic: Choosing the Optimal Dosage Form for Your Molecule
Discover the advantages of liquid-filled, hard-shell capsules (LFHCs), and tablets, as well as which factors come into play when selecting the appropriate oral dosage form for your active pharmaceutical ingredients (APIs). View the infographic.
8. Ask an Altascientist: The Benefits of Nanomilling
Andrew Buis explains the valuable techniques and equipment utilized in nanomilling—a sophisticated process that breaks down API particles into smaller sizes to enhance their surface area and dissolution rate. Watch here.
9. eBook: Regulatory Comparisons for Starting First-in-Human Clinical Trials
FIH trials are a critical first step for your drug development program. This eBook will show you how conducting Phase I research in North America can shorten timelines by as much as six weeks, in comparison to the EU and UK. Read the eBook to learn more.
10. Case Study: Streamlining Clinical Trial Start-up for Accelerated Drug Development
Learn how Altasciences was able to condense the start-up timeline for a Phase I study from the typical 12 weeks to three and a half, by emphasizing effective communication, strategic planning, and delegation of responsibilities. Read the case study.
Recent Regulatory Updates:
• FDA: Guidance Draft – Early Alzheimer’s Disease: Developing Drugs for Treatment
• FDA: Guidance Final Revision – Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products
• FDA: Guidance Final Revision – Clinical Pharmacology Considerations for Antibody-Drug Conjugates
• FDA: Guidance Final Revision – Gene Therapy Products Incorporating Human Genome Editing
• FDA: Final Rule – Biologics License Applications
• FDA: Guidance Draft – Race and Ethnicity Data Terminology in Clinical Trials
• EMA: Guideline – ICH Q14 Analytical Procedure Development
• EMA: Guideline Revision – Clinical Evaluation of Medicinal Products Intended for Treatment of Hepatitis B